<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Palliative care: Overview of mouth care at the end of life
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Palliative care: Overview of mouth care at the end of life
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Palliative care: Overview of mouth care at the end of life
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nathaniel S Treister, DMD, DMSc, DABOM
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alessandro Villa, DDS, PhD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lisa Thompson, DMD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Eduardo Bruera, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jane Givens, MD, MSCE
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 22, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H194519099">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients at the end of life are susceptible to a range of oral complications, including pain, salivary gland dysfunction, dysphagia, and oromucosal infections [
         <a href="#rid1">
          1,2
         </a>
         ]. The oral cavity may be a site of treatment-related side effects in terminally ill patients or may be compromised by the effects of progressive, advanced disease [
         <a href="#rid3">
          3,4
         </a>
         ].
        </p>
        <p>
         This topic provides an overview of the importance of oral health in patients at the end of life as well as and the diagnosis and management of common oral complications. A more extensive discussion of swallowing disorders in palliative care patients is provided elsewhere, as is stomatitis/mucositis related to cancer treatment.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/85949.html" rel="external">
          "Swallowing disorders and aspiration in palliative care: Definition, pathophysiology, etiology, and consequences"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/95508.html" rel="external">
          "Swallowing disorders and aspiration in palliative care: Assessment and strategies for management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1152.html" rel="external">
          "Oral toxicity associated with systemic anticancer therapy"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3408.html" rel="external">
          "Management and prevention of complications during initial treatment of head and neck cancer", section on 'Mucositis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11616553">
         <span class="h1">
          THE IMPORTANCE OF ORAL HEALTH
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral health is essential for communication, eating, speaking, and swallowing. Compromises can impact quality of life and contribute to functional decline and failure to thrive [
         <a href="#rid5">
          5
         </a>
         ]. Oral health care is therefore an integral component of palliative care, with the goals of preventing oral complications, maintaining adequate oral function, and optimizing quality of life and comfort [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         Routine oral hygiene should be maintained in palliative care patients if at all possible (see
         <a class="local">
          'Preventive oral care'
         </a>
         below). In addition, replacing decayed, broken, and/or missing teeth at the end of life should be addressed if it is important to the patient and consistent with the goals of care. (See
         <a class="local">
          'Role of the dentist'
         </a>
         below.)
        </p>
        <p>
         Particular concerns include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eating difficulty can lead to reduced food intake, poor nutrition, weight loss, and changes in facial structure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty with speech and communication can contribute to undue stress and frustration on the part of both patients and their caregivers/families [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A patient’s concerns with facial and oral esthetics may relate to their desire to die with dignity and respect.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Usual oral hygiene practices may be neglected at the end of life [
         <a href="#rid6">
          6
         </a>
         ], which can contribute to gingivitis and/or periodontitis, caries development, tooth loss, and halitosis. This can impact self-esteem, and family and friends may avoid contact with their loved one due to halitosis, worsening the patient’s isolation and depression [
         <a href="#rid3">
          3,8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decayed, broken, and/or missing teeth can compromise mastication as well as increase the likelihood of oral soft tissue trauma and subsequent disability [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Salivary gland dysfunction (mainly xerostomia but also dysgeusia) can influence appetite, bolus formation, and the ability to swallow, as well as speech and communication.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral pain and/or ill-fitting dentures can compromise oral intake and further diminish a patient’s ability to communicate. This problem is especially common in patients with cachexia related to terminal illness.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11616586">
         <span class="h1">
          ORAL HEALTH ASSESSMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         A comprehensive oral health assessment include an oral symptom assessment and clinical examination. In addition, a cognitive assessment, functional assessment, and identification of goals of care provide supporting information. It is important to determine if the patient is capable of maintaining their own oral hygiene and to identify a person to monitor the oral health status of the patient.
        </p>
        <p class="headingAnchor" id="H4081389907">
         <span class="h2">
          Evaluation of symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some preliminary questions for patients include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Do you wear a partial or complete denture? If yes, do you have any problems with your denture? Do you remove your denture at night or for some period of time during the day? How do you clean your denture?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Do any particular foods or drinks cause discomfort?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “What are you doing to care for your mouth and teeth?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Does your mouth or tongue feel dry?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Do you have pain in your mouth, teeth, throat, or when you chew?”
        </p>
        <p>
        </p>
        <p>
         For patients who are experiencing pain, additional questions can include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Where do you have pain in your mouth? Can you point to it?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Do you have any pain when you eat or drink?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Do you have pain in response to hot or cold food or drink?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “How long does the pain last after you eat or drink something?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         “Is it a dull, throbbing, or sharp pain?”
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For nonverbal patients, pain can be assessed by palpating areas identified in the Kayser-Jones Brief Oral Health Assessment Tool (OHAT)  (
         <a class="graphic graphic_table graphicRef102732" href="/z/d/graphic/102732.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         Pain should be quantified using validated tools, although patients at the end of life may only be able to convey nonverbal cues of pain  (
         <a class="graphic graphic_form graphicRef67351" href="/z/d/graphic/67351.html" rel="external">
          form 1
         </a>
         and
         <a class="graphic graphic_form graphicRef50711" href="/z/d/graphic/50711.html" rel="external">
          form 2
         </a>
         ) [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p>
         Patient behaviors may be pain related. The American Geriatrics Society categorizes six types of behavioral pain indicators, which may be helpful in the assessment of oral pain in the nonverbal patient  (
         <a class="graphic graphic_table graphicRef102314" href="/z/d/graphic/102314.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         Pain should be assessed, evaluated, documented, and repeatedly reassessed in all patients using an appropriate pain assessment tool  (
         <a class="graphic graphic_table graphicRef103690" href="/z/d/graphic/103690.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid12">
          12
         </a>
         ]. Family members, friends, and caregivers should also be engaged to participate in the pain assessment.
        </p>
        <p class="headingAnchor" id="H1425305561">
         <span class="h3">
          Oral health assessment tools
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several oral health assessments tools have been developed for health care providers working with geriatric patients [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         The OHAT  (
         <a class="graphic graphic_table graphicRef102732" href="/z/d/graphic/102732.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid14">
          14
         </a>
         ] is a validated instrument that has been used to screen residents of nursing facilities for oral health status, including those with cognitive impairment [
         <a href="#rid15">
          15
         </a>
         ]. It is designed for use by nondental professionals to assess the oral health status of a patient and identify the need for an examination by a dentist. The tool can also be used to establish a patient’s oral health status at baseline, prior to initiating an individualized oral hygiene care plan, and to monitor progress of the intervention. A score of 1 or 2 for any category requires an examination of the patient by a dentist [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1132588552">
         <span class="h2">
          Oral examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         An oral examination should be undertaken to identify the oral pathology and the state of oral hygiene. Oral function related to a patient’s ability to chew food, insert and remove a dental prosthesis, and speak should also be assessed and reported.
        </p>
        <p class="headingAnchor" id="H1428694418">
         <span class="h1">
          ROLE OF THE DENTIST
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is optimal to include a dentist in the interdisciplinary palliative care team, or for one to serve in a consulting role, although this is not always feasible. The role of the dentist is to assess oral health and determine the need for dental interventions. In the absence of a dentist, the palliative care team must be capable of performing an oral health assessment and developing a plan for oral care.
        </p>
        <p>
         The scope of the oral care provided by dentists at the end of life may be restorative, preventive, or simply symptom-based comfort care. It may include extraction of infected or loose teeth and restoring carious teeth with interim restorative materials. The presence of teeth influences appearance, the ability to chew and bite, enjoyment of eating, and oral comfort [
         <a href="#rid9">
          9
         </a>
         ]. Replacing decayed, broken, and/or missing teeth at the end of life should be addressed if it is important to the patient and consistent with the goals of care.
        </p>
        <p>
         Dentists must individualize and prioritize the components of care to correspond to the patient’s health status [
         <a href="#rid17">
          17
         </a>
         ]. In order to minimize overtreatment and/or even potentially harmful interventions at the end of life, treatment plans must be modified over time, based upon the clinical course and/or the patient’s goals of care.
        </p>
        <p class="headingAnchor" id="H931167944">
         <span class="h1">
          PREVENTIVE ORAL CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maintaining good oral hygiene can help reduce gingivitis, periodontitis, halitosis, oral infections, and caries risk. Oral hygiene should be performed at minimum twice daily:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use a soft-bristled toothbrush with an over-the-counter
         <a class="drug drug_general" data-topicid="8462" href="/z/d/drug information/8462.html" rel="external">
          fluoride
         </a>
         toothpaste or a prescription-strength fluoride toothpaste (1.1% sodium fluoride). Place the brush at the gingival margin and use a circular motion to reach all surfaces of the teeth. An electric toothbrush may be more effective for patients with limitations in mobility, coordination, and dexterity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rinse thoroughly with water or an alcohol-free mouthwash to decrease bacterial load and improve halitosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Remove dentures, if present, and brush thoroughly with a denture brush and warm water. Dentures may need to soak in a solution if candidiasis is present.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consider using over-the-counter lip care moisturizers including
         <a class="drug drug_general" data-topicid="101844" href="/z/d/drug information/101844.html" rel="external">
          lanolin
         </a>
         , Oral Balance, unflavored Chapstick, Vaseline, or cocoa butter to moisten lips if dry or chapped [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who are unable to rinse or spit or who have swallowing problems, swab the mouth and teeth twice daily with a sponge toothette soaked in alcohol-free 0.12%
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         gluconate [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients at higher risk for caries due to greater functional or cognitive impairment,
         <a class="drug drug_general" data-topicid="8462" href="/z/d/drug information/8462.html" rel="external">
          fluoride
         </a>
         gels (1.1% sodium fluoride gel) can be applied with a brush and used daily, topical fluoride varnish (5% sodium fluoride varnish, 0.4 mL dose) can be applied at three-month intervals, or silver diamine fluoride (38% silver diamine fluoride) can be applied at three-month intervals [
         <a href="#rid20">
          20-23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11616598">
         <span class="h1">
          COMMON ORAL CONDITIONS AT THE END OF LIFE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common oral problems among terminally ill patients are xerostomia, oral mucosal pain, infections, and problems with eating. Oral complications may be become greater as death approaches [
         <a href="#rid1">
          1,2,24
         </a>
         ].
        </p>
        <p>
         Swallowing disturbances are also common in palliative care patients, especially those with brain tumors, advanced neurologic disorders, and cancers of the upper aerodigestive tract. Dysphagia is a risk factor for aspiration pneumonia and airway obstruction and is addressed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/85949.html" rel="external">
          "Swallowing disorders and aspiration in palliative care: Definition, pathophysiology, etiology, and consequences"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/95508.html" rel="external">
          "Swallowing disorders and aspiration in palliative care: Assessment and strategies for management"
         </a>
         .)
        </p>
        <p>
         Mucositis/stomatitis related to cancer treatment and oral toxicity associated with chemotherapy agents is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3408.html" rel="external">
          "Management and prevention of complications during initial treatment of head and neck cancer", section on 'Mucositis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1152.html" rel="external">
          "Oral toxicity associated with systemic anticancer therapy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H75093682">
         <span class="h2">
          Xerostomia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Xerostomia (dry mouth) can occur in up to 80 percent of patients at the end of life and is a frequent complication of radiation therapy to the head and neck region.
        </p>
        <p>
         Medication review is the first step in management. The primary cause is often the use of one or more xerogenic medications  (
         <a class="graphic graphic_table graphicRef108327" href="/z/d/graphic/108327.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid1">
          1,2,25,26
         </a>
         ]. In one survey, hospice patients with advanced cancer were on a median number of four drugs that were associated with xerostomia [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3365.html" rel="external">
          "Management of late complications of head and neck cancer and its treatment", section on 'Salivary gland damage and xerostomia'
         </a>
         .)
        </p>
        <p>
         Complications of hyposalivation include rampant tooth decay and oral candidiasis. Dry mouth and limited oral intake may also lead to an over-keratinization of the tongue dorsum (“hairy tongue”)  (
         <a class="graphic graphic_picture graphicRef102280" href="/z/d/graphic/102280.html" rel="external">
          picture 1
         </a>
         ). Basic measures for dry mouth include minimizing use of pharmacologic therapies associated with salivary hypofunction  (
         <a class="graphic graphic_table graphicRef108327" href="/z/d/graphic/108327.html" rel="external">
          table 4
         </a>
         ), improved hydration, use of humidifiers, sugar-free chewing gums or candy, and mucosal lubricants/saliva substitutes. Use of prescription sialogogues is generally not indicated in end-of-life care.
        </p>
        <p class="headingAnchor" id="H755787963">
         <span class="h2">
          Excess salivation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sialorrhea or excess salivation may be caused by neuromuscular dysfunctions in patients with amyotrophic lateral sclerosis (ALS), cerebral palsy, stroke, and Parkinson disease [
         <a href="#rid28">
          28
         </a>
         ]. It may also occur in patients affected by Alzheimer disease or myasthenia gravis who take drugs with reversible cholinesterase inhibitor activity. Saliva pools in the mouth due to a lack of swallowing rather than a true salivary gland hyperfunction. Symptoms can be embarrassing and socially disabling. Sialorrhea can contribute to skin irritation, poor oral health, and dehydration and can increase the risk of aspiration pneumonia.
        </p>
        <p>
         For clinically significant sialorrhea, anticholinergic medications may be helpful  (
         <a class="graphic graphic_table graphicRef81557" href="/z/d/graphic/81557.html" rel="external">
          table 5
         </a>
         ), particularly
         <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">
          glycopyrrolate
         </a>
         because of its relatively low central nervous system activity. Intrasalivary gland injection of botulinum toxin A may be beneficial. For refractory cases, radiation therapy to the parotid and submandibular glands could be considered. However, each of these treatment options has significant side effects and may be contraindicated or poorly tolerated in various populations. A portable suction device can assist in temporary evacuation of secretions, although its effect is usually short lived. (See
         <a class="medical medical_review" href="/z/d/html/4900.html" rel="external">
          "Management of nonmotor symptoms in Parkinson disease", section on 'Sialorrhea'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5129.html" rel="external">
          "Symptom-based management of amyotrophic lateral sclerosis", section on 'Sialorrhea'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/95508.html" rel="external">
          "Swallowing disorders and aspiration in palliative care: Assessment and strategies for management", section on 'Sialorrhea'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11616637">
         <span class="h2">
          Orofacial pain conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Orofacial pain conditions of noninfectious etiology, such as myofascial pain and neuropathic pain disorders, may be encountered in up to two-thirds of patients at the end of life [
         <a href="#rid1">
          1,2
         </a>
         ]. A careful history and physical examination may help to discriminate between odontogenic and other sources of pain. All patients with craniofacial pain syndromes should be evaluated by a dentist, should be instructed to maintain a soft diet, and should perform passive jaw-stretching exercises.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Myofascial pain
         </strong>
         – Parafunctional habits such as clenching and grinding of the teeth may lead to myofascial pain, with or without secondary temporomandibular joint arthralgia. Patients may complain of a dull, aching pain that is exacerbated with wide opening of the jaw and chewing [
         <a href="#rid10">
          10
         </a>
         ]. Myofascial pain may present at the end of life even in patients with no prior history or known risk factors. (See
         <a class="medical medical_review" href="/z/d/html/5629.html" rel="external">
          "Temporomandibular disorders in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Management of myofascial pain includes systemic (eg,
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         ,
         <a class="drug drug_general" data-topicid="9682" href="/z/d/drug information/9682.html" rel="external">
          naproxen
         </a>
         ) and topical (eg,
         <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">
          diclofenac
         </a>
         1% gel) antiinflammatory therapy and, in severe cases, the use of muscle relaxants and a low dose of anxiolytics or antidepressants. Topical antiinflammatory preparations should be applied multiple times throughout the day to the affected areas. When trigger points are identified, intralesional therapy with corticosteroids and/or local anesthetics without
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         can be effective. (See
         <a class="medical medical_review" href="/z/d/html/14248.html" rel="external">
          "Interventional therapies for chronic pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Trigeminal neuralgia
         </strong>
         – Trigeminal neuralgia is a painful paroxysmal neuropathic facial pain condition; its prevalence increases with age. Trigeminal neuralgia is characterized by intense unilateral electric shock-like pain in the distribution of one division of the trigeminal nerve. (See
         <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">
          "Trigeminal neuralgia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Most cases of trigeminal neuralgia are effectively managed with
         <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">
          carbamazepine
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">
          "Trigeminal neuralgia", section on 'First-line therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuropathic pain
         </strong>
         – Central neuropathic facial pain may be a complication of multiple sclerosis or a stroke (see
         <a class="medical medical_review" href="/z/d/html/3324.html" rel="external">
          "Central neuropathic facial pain"
         </a>
         ). Persistent idiopathic facial pain is a neuropathic pain condition characterized by constant oral or facial pain in the absence of a known cause; it is often mistakenly attributed to odontogenic infection. (See
         <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">
          "Overview of craniofacial pain", section on 'Persistent idiopathic facial pain'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment for persistent idiopathic facial pain includes low-dose tricyclic antidepressants,
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         ,
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         , or
         <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">
          pregabalin
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">
          "Overview of craniofacial pain", section on 'Persistent idiopathic facial pain'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Oral dysesthesia –
         </strong>
         Oral dysesthesia is typically characterized by oral burning in the absence of physical causes with other associated symptoms, including tingling, taste changes, and xerostomia. This condition is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">
          "Overview of craniofacial pain", section on 'Burning mouth syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Osteonecrosis of the jaw
         </strong>
         – Jaw pain may also be due to osteonecrosis of the jaw, which may be a long-term complication of radiation therapy to the head and neck (osteoradionecrosis) or medication related (most often from the use of antiresorptive therapy [high-dose bisphosphonates and
         <a class="drug drug_general" data-topicid="15575" href="/z/d/drug information/15575.html" rel="external">
          denosumab
         </a>
         ] among patients with skeletal metastases). (See
         <a class="medical medical_review" href="/z/d/html/96863.html" rel="external">
          "Medication-related osteonecrosis of the jaw in patients with cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3365.html" rel="external">
          "Management of late complications of head and neck cancer and its treatment", section on 'Osteoradionecrosis and soft tissue necrosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4277262253">
         <span class="h2">
          Dental caries
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients at the end of life may be at a greater risk for caries due to hyposalivation and/or decreased oral care [
         <a href="#rid17">
          17
         </a>
         ]. Dental caries can be diagnosed on clinical examination in most cases, but intraoral dental radiographs may be necessary  (
         <a class="graphic graphic_diagnosticimage graphicRef102273" href="/z/d/graphic/102273.html" rel="external">
          image 1
         </a>
         ). Large dental caries may lead to pulpal necrosis and secondary infection (abscess)  (
         <a class="graphic graphic_picture graphicRef102272" href="/z/d/graphic/102272.html" rel="external">
          picture 2
         </a>
         ). If untreated, an odontogenic infection may lead to pain/swelling, trismus, risk of sepsis, and other life-threatening complications. (See
         <a class="medical medical_review" href="/z/d/html/3416.html" rel="external">
          "Complications, diagnosis, and treatment of odontogenic infections"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention and treatment
         </strong>
         – The risk of developing dental caries can be reduced with good oral hygiene at bedside, low consumption of carbohydrates, and use of topical
         <a class="drug drug_general" data-topicid="8462" href="/z/d/drug information/8462.html" rel="external">
          fluoride
         </a>
         preparations, including fluoride varnishes and silver diamine fluoride [
         <a href="#rid20">
          20-22
         </a>
         ]. Caries can simply be monitored unless symptomatic or considered at high risk for fracture and/or abscess formation. Gross decay with pulpal involvement requires dental extraction. For patients with dental phobia or anxiety, the use of a fast- and short-acting benzodiazepine prior to dental extractions or restorations can be useful [
         <a href="#rid29">
          29
         </a>
         ]. Palliative management includes delivery of caries arresting chemotherapeutics (application of 38% silver diamine fluoride) [
         <a href="#rid30">
          30
         </a>
         ], temporary restorations, and antibiotics in cases of acute infections.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2736730218">
         <span class="h2">
          Periodontal disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Compromised oral hygiene is common in patients at the end of life, and this can contribute to gingivitis and periodontitis  (
         <a class="graphic graphic_picture graphicRef102274" href="/z/d/graphic/102274.html" rel="external">
          picture 3
         </a>
         ). Periodontitis is a disease that affects the tissues surrounding the teeth (the gingiva, periodontal ligament, and alveolar bone). The clinical signs of periodontal disease include the presence of plaque and calculus; bleeding on probing, flossing, or brushing of the teeth and gums; periodontal pockets; and mobile teeth. In addition to the localized periodontal condition, the role of medications/medical conditions, such as calcium channel blockers, hypertension, and uncontrolled diabetes, can contribute to bleeding gums [
         <a href="#rid31">
          31
         </a>
         ]. If untreated, periodontal disease may lead to abscess formation, tooth mobility, and subsequent tooth loss. (See
         <a class="medical medical_review" href="/z/d/html/6858.html" rel="external">
          "Overview of gingivitis and periodontitis in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention and treatment
         </strong>
         – Treatment of periodontal disease in palliative care patients includes improvement of oral hygiene practices (eg, use of interproximal brushes) and antimicrobial therapies with topical
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         gluconate and/or systemic antibiotics, if appropriately aligned with the patient’s goals of care [
         <a href="#rid32">
          32
         </a>
         ]. Localized scaling to remove obvious calculus deposits may be helpful. Extraction of loose teeth should be considered when there is aspiration risk.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9659322">
         <span class="h2">
          Odontogenic infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most oral bacterial infections are odontogenic and originate from an infection of the dental pulp secondary to dental caries, or from the periodontium in patients with advanced or untreated periodontal disease. The different types of odontogenic infections are outlined in the figure and discussed in more detail elsewhere  (
         <a class="graphic graphic_figure graphicRef65240" href="/z/d/graphic/65240.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – A dentist should assess the patient for the location, severity, and symptoms of the infection. Acute and chronic odontogenic infections should be treated with antibiotics, analgesics, and/or root canal therapy or tooth extraction. In most cases, tooth extraction is recommended due to the difficulty in scheduling multiple visits for root canal therapy and subsequent tooth restoration. Considerations for extraction include gross tooth decay, tooth mobility, or a fractured tooth and root tips. It should be noted that the coordination of care may be challenging and prevent definitive treatment. In this case, relieving symptoms with antibiotic treatment and/or analgesics should be administered with appropriate follow-up to determine if the infection has subsided. The course of action should be appropriately aligned with the patient’s goals of care.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2693174378">
         <span class="h2">
          Viral infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Herpes simplex virus type 1 (HSV-1), also known as herpes labialis, is the etiologic agent of vesicular lesions of the lips, tongue, and oral mucosa, commonly referred to as “cold sores.” Recrudescence of HSV-1 infection is common in debilitated patients, most frequently presenting as ulceration of the commissures of the lips and, less frequently, intraorally. Intraoral mucosal ulcerations are painful and characterized by shallow irregular margins  (
         <a class="graphic graphic_picture graphicRef102275" href="/z/d/graphic/102275.html" rel="external">
          picture 4
         </a>
         and
         <a class="graphic graphic_picture graphicRef102276" href="/z/d/graphic/102276.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef102277" href="/z/d/graphic/102277.html" rel="external">
          picture 6
         </a>
         ). Oral ulcers suspicious for HSV-1 should be swabbed for culture or polymerase chain reaction (PCR) to rule out viral infection.
        </p>
        <p>
         Antiviral therapy with
         <a class="drug drug_general" data-topicid="9335" href="/z/d/drug information/9335.html" rel="external">
          acyclovir
         </a>
         or
         <a class="drug drug_general" data-topicid="10034" href="/z/d/drug information/10034.html" rel="external">
          valacyclovir
         </a>
         should be initiated if this is in keeping with the patient’s goals of care. Supportive care includes nutritional support and adequate hydration. Pain must be managed appropriately with topical/systemic analgesics [
         <a href="#rid33">
          33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection"
         </a>
         .)
        </p>
        <p>
         Oral ulceration secondary to cytomegalovirus (CMV) infection in immunocompromised individuals is a rare occurrence. If a diagnosis of CMV infection is suspected, an oral biopsy may be obtained and submitted for histopathological examination and viral isolation.
        </p>
        <p class="headingAnchor" id="H240224162">
         <span class="h2">
          Fungal infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oropharyngeal candidiasis is a frequent mucosal infection in palliative care patients, seen in up to one-third of patients [
         <a href="#rid2">
          2
         </a>
         ]. Multiple contributing risk factors include poor oral hygiene, dry mouth, wearing of dentures, diabetes mellitus, antibiotic use, and long-term immunosuppression [
         <a href="#rid34">
          34
         </a>
         ]. The usual causative agent is
         <em>
          Candida albicans
         </em>
         , but other species, including
         <em>
          Candida glabrata
         </em>
         ,
         <em>
          Candida krusei
         </em>
         , and
         <em>
          Candida tropicalis
         </em>
         , have been isolated. (See
         <a class="medical medical_review" href="/z/d/html/2416.html" rel="external">
          "Overview of Candida infections", section on 'Oropharyngeal candidiasis'
         </a>
         .)
        </p>
        <p>
         There are several forms of oropharyngeal candidiasis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The pseudomembranous form (“thrush”) is the most common and appears as white to yellowish curd-like papules and plaques on the buccal mucosa, palate, tongue, or oropharynx that can be easily wiped away, leaving a bleeding base  (
         <a class="graphic graphic_picture graphicRef102278" href="/z/d/graphic/102278.html" rel="external">
          picture 7
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The atrophic form, also called denture stomatitis, is the most common form in older adults. It is often found under upper dentures and is characterized by diffuse erythema without plaques  (
         <a class="graphic graphic_picture graphicRef79519" href="/z/d/graphic/79519.html" rel="external">
          picture 8
         </a>
         ) [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperplastic candidiasis is a rare chronic variant that manifests with white plaques that do not rub off, suggestive of leukoplakia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Candidal infection may also cause angular cheilitis with painful erythematous fissures at the labial commissures  (
         <a class="graphic graphic_picture graphicRef102279" href="/z/d/graphic/102279.html" rel="external">
          picture 9
         </a>
         ). In some cases, there may be a bacterial component that would need to be treated.
        </p>
        <p>
        </p>
        <p>
         Many patients with oropharyngeal candidiasis are asymptomatic. The most common symptoms that do occur are a cottony feeling in the mouth, loss of taste, and, in some cases, pain during eating and swallowing. Patients who have denture stomatitis usually experience pain. (See
         <a class="medical medical_review" href="/z/d/html/2427.html" rel="external">
          "Esophageal candidiasis in adults"
         </a>
         .)
        </p>
        <p>
         Treatment includes topical and systemic antifungal medications.
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          Fluconazole
         </a>
         is highly effective and generally easier to dose as it is a single daily tablet. Commonly used topical agents include
         <a class="drug drug_general" data-topicid="9712" href="/z/d/drug information/9712.html" rel="external">
          nystatin
         </a>
         suspension and
         <a class="drug drug_general" data-topicid="9287" href="/z/d/drug information/9287.html" rel="external">
          clotrimazole
         </a>
         troches. It is imperative to also clean dentures regularly. Dentures should be cleaned and soaked in 3% sodium hypochlorite diluted in water (1:10) or an antibacterial solution (eg,
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         digluconate 0.12 to 2%) or the nystatin suspension overnight. Angular cheilitis is effectively managed with topical nystatin/
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         cream or ointment.
        </p>
        <p class="headingAnchor" id="H1082184479">
         <span class="h1">
          MOUTH CARE IN THE LAST HOURS OF LIFE
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the last hours of life, we recommend prioritizing the following oral care to provide comfort care to a dying patient:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For dry, cracked lips, consider using over-the-counter lip care moisturizers including
         <a class="drug drug_general" data-topicid="101844" href="/z/d/drug information/101844.html" rel="external">
          lanolin
         </a>
         , Oral Balance, unflavored Chapstick, Vaseline, or cocoa butter to moisten lips [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who are unable to rinse or spit, have swallowing problems, or have difficulty brushing their teeth, swab the mouth and teeth twice daily with a sponge toothette soaked in alcohol-free 0.12%
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         gluconate [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who can drink and swallow, provide ice chips or water.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Remove dentures, if present, and brush thoroughly with a denture brush and warm water.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2721158934">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/119531.html" rel="external">
          "Society guideline links: Palliative care"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1950125952">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral health is essential for carrying out activities of daily living such as communication, eating, speaking, and swallowing. Oral complications that can arise in terminally ill patients, such as pain, salivary gland dysfunction, dysphagia, and oromucosal infections, can impact quality of life and contribute to functional decline and failure to thrive. Oral health care is an integral component of palliative care, with the goals of preventing oral complications, maintaining adequate oral function, and optimizing quality of life and comfort. (See
         <a class="local">
          'The importance of oral health'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The role of the dentist is to maintain and improve quality of life by assessing oral health and status and determining the need for any dental interventions. The scope of the oral care provided by dentists at the end of life can include restorative, preventive, and symptom-based comfort care. The dentist needs to individualize and prioritize care in a way that corresponds to the patient’s evolving health status and overall goals of care. (See
         <a class="local">
          'Role of the dentist'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Routine oral hygiene should be maintained in palliative care patients if at all possible. Maintaining good oral hygiene can help reduce gingivitis, periodontitis, halitosis, oral infections, and caries risk. Oral hygiene should be performed at minimum twice daily. (See
         <a class="local">
          'Preventive oral care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Replacing decayed, broken, and/or missing teeth at the end of life should be addressed if it is important to the patient and consistent with the goals of care. (See
         <a class="local">
          'Role of the dentist'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Caries can simply be monitored unless symptomatic or considered at high risk for fracture and/or abscess formation. Gross decay with pulpal involvement requires dental extraction. Palliative management includes temporary restorations and antibiotics in cases of acute infections. (See
         <a class="local">
          'Odontogenic infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment of periodontal disease includes improved oral hygiene practices (eg, use of interproximal brushes, localized scaling if necessary) and antimicrobial therapies if appropriately aligned with the patient’s goals of care. Extraction of loose teeth should be considered when there is aspiration risk. (See
         <a class="local">
          'Periodontal disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Salivary gland dysfunction in terminally ill patients can manifest as salivary gland hypofunction, most often related to use of xerogenic medications  (
         <a class="graphic graphic_table graphicRef108327" href="/z/d/graphic/108327.html" rel="external">
          table 4
         </a>
         ), or excessive salivary flow (sialorrhea). For clinically significant sialorrhea, anticholinergic medications may be helpful  (
         <a class="graphic graphic_table graphicRef81557" href="/z/d/graphic/81557.html" rel="external">
          table 5
         </a>
         ), particularly
         <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">
          glycopyrrolate
         </a>
         . (See
         <a class="local">
          'Xerostomia'
         </a>
         above and
         <a class="local">
          'Excess salivation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dysphagia is common in patients at the end of life, especially those with brain tumors, advanced neurologic disorders, and cancers of the upper aerodigestive tract. Swallowing dysfunction may lead to communication impairment, dehydration, and poor nutrition, and it is a risk factor for aspiration pneumonia and airway obstruction. Management of patients with swallowing difficulties is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/95508.html" rel="external">
          "Swallowing disorders and aspiration in palliative care: Assessment and strategies for management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For infection with herpes simplex virus type 1 (HSV-I), antiviral therapy with
         <a class="drug drug_general" data-topicid="9335" href="/z/d/drug information/9335.html" rel="external">
          acyclovir
         </a>
         or
         <a class="drug drug_general" data-topicid="10034" href="/z/d/drug information/10034.html" rel="external">
          valacyclovir
         </a>
         should be initiated if this is in keeping with the patient’s goals of care; appropriate analgesia should be addressed. (See
         <a class="local">
          'Viral infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment for oral candidiasis includes topical and systemic antifungal medications. Angular cheilitis is effectively managed with topical
         <a class="drug drug_general" data-topicid="9712" href="/z/d/drug information/9712.html" rel="external">
          nystatin
         </a>
         /
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         cream or ointment. (See
         <a class="local">
          'Fungal infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Odontogenic infections should be treated with antibiotics, analgesics, and/or definitive treatment of the affected tooth (extraction, root canal with restoration) if the patient can tolerate the procedure. If definitive treatment cannot be performed, relieving symptoms with antibiotic treatment and/or analgesics should be administered with appropriate follow-up to determine if the infection has subsided. (See
         <a class="local">
          'Odontogenic infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Orofacial pain conditions of noninfectious etiology, such as myofascial pain, neuropathic pain disorders, and jaw osteonecrosis, may be encountered in patients at the end of life. A careful history and physical examination may help to discriminate between odontogenic and other sources of pain. All patients with orofacial pain should be evaluated by a dentist, should be instructed to maintain a soft diet, and should perform passive jaw-stretching exercises. Management is specific to the condition. (See
         <a class="local">
          'Orofacial pain conditions'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Aldred MJ, Addy M, Bagg J, Finlay I. Oral health in the terminally ill: a cross-sectional pilot survey. Spec Care Dentist 1991; 11:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB. Oral health is an important issue in end-of-life cancer care. Support Care Cancer 2012; 20:3115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiseman M. The treatment of oral problems in the palliative patient. J Can Dent Assoc 2006; 72:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walls AW, Murray ID. Dental care of patients in a hospice. Palliat Med 1993; 7:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer DJ, Epstein JB, Yao Y, Wilkie DJ. Oral health conditions affect functional and social activities of terminally ill cancer patients. Support Care Cancer 2014; 22:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen X, Chen H, Douglas C, et al. Dental treatment intensity in frail older adults in the last year of life. J Am Dent Assoc 2013; 144:1234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilwert M. Should dentists be included as members of the hospice care team? Spec Care Dentist 2003; 23:84.
          </a>
         </li>
         <li class="breakAll">
          Wiseman M. Palliative care dentistry. In: Geriatric Dentistry: Caring For Our Aging Population, 1st ed, Friedman PK (Ed), John Wiley &amp; Sons, Ames, IA 2014. p.17.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strauss RP, Hunt RJ. Understanding the value of teeth to older adults: influences on the quality of life. J Am Dent Assoc 1993; 124:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller KE, Miller MM, Jolley MR. Challenges in pain management at the end of life. Am Fam Physician 2001; 64:1227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lobbezoo F, Weijenberg RA, Scherder EJ. Topical review: orofacial pain in dementia patients. A diagnostic challenge. J Orofac Pain 2011; 25:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herr K, Coyne PJ, Key T, et al. Pain assessment in the nonverbal patient: position statement with clinical practice recommendations. Pain Manag Nurs 2006; 7:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Everaars B, Weening-Verbree LF, Jerković-Ćosić K, et al. Measurement properties of oral health assessments for non-dental healthcare professionals in older people: a systematic review. BMC Geriatr 2020; 20:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kayser-Jones J, Bird WF, Paul SM, et al. An instrument to assess the oral health status of nursing home residents. Gerontologist 1995; 35:814.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers JM, King PL, Spencer AJ, et al. The oral health assessment tool--validity and reliability. Aust Dent J 2005; 50:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers J, Johnson V, Tang JH, Titler MG. Evidence-based protocol: oral hygiene care for functionally dependent and cognitively impaired older adults. J Gerontol Nurs 2004; 30:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen X, Clark JJ, Preisser JS, et al. Dental caries in older adults in the last year of life. J Am Geriatr Soc 2013; 61:1345.
          </a>
         </li>
         <li class="breakAll">
          Siegel MA, Sollecito TP, Stoopler ET. Clinician's Guide to Treatment of Common Oral Conditions, 8th ed, American Academy of Oral Medicine, 2017.
         </li>
         <li class="breakAll">
          Chalmers JM, Wiseman M, Ettinger R, Spector EL. Oral Hygiene Care for Palliative Care Residents in Nursing Homes. In: Center IGE (Ed), 2009. p.1.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horst JA, Ellenikiotis H, Milgrom PL. UCSF Protocol for Caries Arrest Using Silver Diamine Fluoride: Rationale, Indications and Consent. J Calif Dent Assoc 2016; 44:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillette J. Caries Arresting Approaches for Aging and Medically Complex Patients. J Calif Dent Assoc 2018; 46:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oliveira BH, Cunha-Cruz J, Rajendra A, Niederman R. Controlling caries in exposed root surfaces with silver diamine fluoride: A systematic review with meta-analysis. J Am Dent Assoc 2018; 149:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pretty IA, Ellwood RP, Lo EC, et al. The Seattle Care Pathway for securing oral health in older patients. Gerodontology 2014; 31 Suppl 1:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsuo K, Watanabe R, Kanamori D, et al. Associations between oral complications and days to death in palliative care patients. Support Care Cancer 2016; 24:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villa A, Wolff A, Narayana N, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Dis 2016; 22:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolff A, Joshi RK, Ekström J, et al. A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs R D 2017; 17:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manage 2001; 22:820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician 2004; 69:2628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matear DW, Clarke D. Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: a review of the literature. Spec Care Dentist 1999; 19:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crystal YO, Niederman R. Evidence-Based Dentistry Update on Silver Diamine Fluoride. Dent Clin North Am 2019; 63:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers 2017; 3:17038.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366:1809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl:S12.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002; 78:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Budtz-Jørgensen E. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol 1981; 10:65.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 86293 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1831294" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Oral health in the terminally ill: a cross-sectional pilot survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22434497" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Oral health is an important issue in end-of-life cancer care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16772071" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The treatment of oral problems in the palliative patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8261198" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Dental care of patients in a hospice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24232310" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Oral health conditions affect functional and social activities of terminally ill cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24177401" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Dental treatment intensity in frail older adults in the last year of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14650555" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Should dentists be included as members of the hospice care team?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14650555" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Should dentists be included as members of the hospice care team?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8445136" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Understanding the value of teeth to older adults: influences on the quality of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11601805" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Challenges in pain management at the end of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21359232" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Topical review: orofacial pain in dementia patients. A diagnostic challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16730317" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Pain assessment in the nonverbal patient: position statement with clinical practice recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31900125" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Measurement properties of oral health assessments for non-dental healthcare professionals in older people: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8557208" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : An instrument to assess the oral health status of nursing home residents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16238218" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The oral health assessment tool--validity and reliability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15575186" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Evidence-based protocol: oral hygiene care for functionally dependent and cognitively impaired older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23865859" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Dental caries in older adults in the last year of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23865859" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Dental caries in older adults in the last year of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23865859" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Dental caries in older adults in the last year of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26897901" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : UCSF Protocol for Caries Arrest Using Silver Diamine Fluoride: Rationale, Indications and Consent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Caries Arresting Approaches for Aging and Medically Complex Patients
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29805039" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Controlling caries in exposed root surfaces with silver diamine fluoride: A systematic review with meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24446984" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The Seattle Care Pathway for securing oral health in older patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25962615" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Associations between oral complications and days to death in palliative care patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26602059" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27853957" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11576798" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Xerostomia in patients with advanced cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15202698" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Sialorrhea: a management challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11833107" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30447792" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Evidence-Based Dentistry Update on Silver Diamine Fluoride.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28805207" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Periodontal diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16298220" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Periodontal diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17379150" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Management of recurrent oral herpes simplex infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12185216" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Oral candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6792333" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Oral mucosal lesions associated with the wearing of removable dentures.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
